Literature DB >> 20632018

What is the most common complication after one-stage transanal pull-through in infants with Hirschsprung's disease?

M Rouzrokh1, A T Khaleghnejad, L Mohejerzadeh, A Heydari, H Molaei.   

Abstract

BACKGROUND: Hirschsprung's disease (HD) is a relatively common congenital disease that could be suspected by clinical symptoms, abdominal plain X-ray, and finally diagnosed by rectal biopsy. In 80% cases, rectosigmoid junction is involved. Recently, one-stage transanal pull-through (TAPT) procedure has been popular and may have several complications. METHODS AND PATIENTS: During a 4-year period, 86 infants (28 girls, 58 boys) with mean age 8 days (3-33) and clinically suspected to HD were admitted in our center. HD was proved by rectal biopsy. All patients after full bowel preparation and rectal washout were candidates for TAPT operation. A Swenson-like procedure was performed and the anastomosis was done between the well blood supply ganglionic colon and the rectum at 1 cm above dentate line. Interrupted suture with 5-0 Vicryl was used. Nelaton tube (12 F) inserted in the pelvis via transprineal for drainage of blood or collection. From February 2008 in 30 cases, prophylactic Hegar dilatation was performed 2 weeks after operation.
RESULTS: Anal stricture in 12 cases (14%) was treated by anal dilation in 10 cases and 2 cases corrected by surgical management. Entrocolitis in 4 cases (5%) was treated by medical management. In two cases, retrocolic abscess had spontaneous drainage via tube drain. There was no anastomotic stricture after starting prophylactic anal bouginage.
CONCLUSION: TAPT has many advantages, low complications and the results are excellent. It seems the most common complication is anastomotic stricture that responds well to prophylactic bouginage. We recommend prophylactic anal bouginage with Hegar probe at 2 weeks after operation. Long-term follow-up is needed to evaluate the outcomes of our operations.

Entities:  

Mesh:

Year:  2010        PMID: 20632018     DOI: 10.1007/s00383-010-2648-8

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  22 in total

1.  Transanal versus open endorectal pull-through for Hirschsprung's disease.

Authors:  L De la Torre; A Ortega
Journal:  J Pediatr Surg       Date:  2000-11       Impact factor: 2.545

Review 2.  New insights into the pathogenesis of Hirschsprung's associated enterocolitis.

Authors:  Feilim Murphy; Prem Puri
Journal:  Pediatr Surg Int       Date:  2005-09-30       Impact factor: 1.827

3.  Surgical treatment of anal stenosis.

Authors:  Giuseppe Brisinda; Serafino Vanella; Federica Cadeddu; Gaia Marniga; Pasquale Mazzeo; Francesco Brandara; Giorgio Maria
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

4.  Diagnosis of congenital megacolon: an analysis of 501 patients.

Authors:  O Swenson; J O Sherman; J H Fisher
Journal:  J Pediatr Surg       Date:  1973-10       Impact factor: 2.545

5.  Primary transanal Swenson pull-through operation for Hirschsprung's disease.

Authors:  Paiboon Sookpotarom; Paisarn Vejchapipat
Journal:  Pediatr Surg Int       Date:  2009-09       Impact factor: 1.827

6.  A decade of experience with the primary pull-through for hirschsprung disease in the newborn period: a multicenter analysis of outcomes.

Authors:  D H Teitelbaum; R E Cilley; N J Sherman; D Bliss; N D Uitvlugt; E J Renaud; I Kirstioglu; T Bengston; A G Coran
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

7.  Further evidence on totally transanal one-stage pull-through procedure for Hirschsprung's disease.

Authors:  George Ekema; Diego Falchetti; Fabio Torri; Vittorio E Merulla; Alessandro Manciana; Guido Caccia
Journal:  J Pediatr Surg       Date:  2003-10       Impact factor: 2.545

8.  Duhamel operation vs neonatal transanal endorectal pull-through procedure for Hirschsprung disease: which are the changes for pathologists?

Authors:  Dominique Berrebi; Virginie Fouquet; Pascal de Lagausie; Elisabeth Carricaburu; Latita Ferkdadji; Pascale Chomette; Goharig Enezian; Nadia Ezzahir; Michel Peuchmaur; Yves Aigrain
Journal:  J Pediatr Surg       Date:  2007-04       Impact factor: 2.545

9.  MUC-2 mucin production in Hirschsprung's disease: possible association with enterocolitis development.

Authors:  Aladdein F Mattar; Arnold G Coran; Daniel H Teitelbaum
Journal:  J Pediatr Surg       Date:  2003-03       Impact factor: 2.545

10.  Surgical treatment of anal stenosis: assessment of 77 anoplasties.

Authors:  Angelita Habr-Gama; Carlos Walter Sobrado; Sergio Eduardo Alonso de Araújo; Sergio Carlos Nahas; Ingrid Birbojm; Caio Sergio Rizkallah Nahas; Desidério Roberto Kiss
Journal:  Clinics (Sao Paulo)       Date:  2005-03-01       Impact factor: 2.365

View more
  4 in total

1.  Subtotal colectomy with a single-incision laparoscopic surgery technique in children with long-segment Hirschsprung disease and allied disorders.

Authors:  Tianqi Zhu; Jiexiong Feng; Wen Zhang; Mingfa Wei; Donghai Yu; Xueqin Zhang; Kechi Yu; Houfang Kuang
Journal:  Pediatr Surg Int       Date:  2012-12-13       Impact factor: 1.827

2.  The incidence of different forms of ileus following surgery for abdominal birth defects in infants: a systematic review with a meta-analysis method.

Authors:  Laurens D Eeftinck Schattenkerk; Gijsbert D Musters; David J Nijssen; Wouter J de Jonge; Ralph de Vries; L W Ernest van Heurn; Joep P M Derikx
Journal:  Innov Surg Sci       Date:  2021-08-17

3.  Optimal time for single-stage pull-through colectomy in infants with short-segment Hirschsprung disease.

Authors:  Tianqi Zhu; Xiaoyi Sun; Mingfa Wei; Bin Yi; Xiang Zhao; Wenjing Wang; Jiexiong Feng
Journal:  Int J Colorectal Dis       Date:  2018-10-27       Impact factor: 2.571

4.  Can We Rely on Frozen Sections of a Rectal Biopsy for One-stage Trans-anal Pull-through Operation in Hirschsprung's Disease?

Authors:  Mohsen Rouzrokh; Farzaneh Jadali; Atoosa Gharib; Ahmad Khaleghnejad-Tabari; Azita Tavassoli; Leily Mohajerzadeh
Journal:  Iran J Pediatr       Date:  2011-03       Impact factor: 0.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.